HIV

Linee Guida Italiane sull’utilizzo della Terapia Antiretrovirale e la gestione diagnostico-clinica delle persone con infezione da HIV-1 – SIMIT e Ministero della salute (2017)

https://www.salute.gov.it/imgs/C_17_pubblicazioni_2696_allegato.pdf

Linee Guida Italiane sull’utilizzo della Terapia Antiretrovirale e la gestione diagnostico-clinica delle persone con infezione da HIV-1 – SIMIT e Ministero della salute (2017)

https://www.eacsociety.org/media/guidelines-10.1_30032021_1.pdf]

Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach – WHO (luglio 2017)

https://www.who.int/publications/i/item/9789240031593

Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV – Departement of Health and Human service USA(2021)

https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/AdultandAdolescentGL.pdf]

NICE guidelines (01/12/2016)

https://www.nice.org.uk/guidance/ng60

ANTIMICROBICI

NICE guidelines (2016)

https://www.nice.org.uk/guidance/qs121/resources/antimicrobial-stewardship-pdf-75545353537477

Linee Guida Ministero della Salute

https://www.salute.gov.it/portale/news/p3_2_1_1_1.jsp?lingua=italiano&menu=notizie&p=dalministero&id=5234

WHO Global Strategy for Containment of Antimicrobial Resistance (2001)

https://www.who.int/drugresistance/WHO_Global_Strategy_English.pdf

ANTIMICOTICI

Linee guida EMA (2010)

https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-clinical-evaluation-antifungal-agents-treatment-prophylaxis-invasive-fungal-disease_en.pdf

 

COVID

Farmaci utilizzabili per il trattamento della malattia COVID-19 AIFA

https://www.aifa.gov.it/aggiornamento-sui-farmaci-utilizzabili-per-il-trattamento-della-malattia-covid19

COVID-19 Treatment Guidelines of National Institutes of Health

https://www.covid19treatmentguidelines.nih.gov